📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Torrey Pines Therapeutics

1.1 - Company Overview

Torrey Pines Therapeutics Logo

Torrey Pines Therapeutics

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of small molecule drug discovery and development in the United States, with a portfolio comprising candidates from proprietary drug-targeting platforms and in-licensed/acquired programs. As of August 31, 2010, the company's pipeline includes three clinical development programs.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Torrey Pines Therapeutics

Eledon Pharmaceuticals Logo

Eledon Pharmaceuticals

HQ: United States Website
  • Description: Provider of biotechnology therapies and clinical programs for organ and cellular transplantation, featuring tegoprubart, a therapeutic antibody to regulate immune response and prevent rejection. Offers the Phase 2 BESTOW kidney transplant trial, support resources for transplant patients, and R&D in ALS, xenotransplantation, and islet cell transplantation.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Eledon Pharmaceuticals company profile →
ElectroCore Logo

ElectroCore

HQ: United States Website
  • Description: Provider of neuromodulation therapies for the non-invasive treatment of diseases and disorders, including gammaCore and gammaCore Sapphire devices offering non-invasive vagus nerve stimulation for migraine and cluster headache treatment; Truvaga, a natural solution designed to enhance mental clarity and overall health; and TAC-STIM, a portable device aimed at the military for vagus nerve stimulation with quick administration and long-lasting benefits.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full ElectroCore company profile →
Labrys Biologics Logo

Labrys Biologics

HQ: United States Website
  • Description: Provider of treatments for chronic migraine, developing RN-307, an antibody for chronic migraine, with worldwide rights acquired from Pfizer.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Labrys Biologics company profile →
Sapiens Logo

Sapiens

HQ: Germany Website
  • Description: Provider of medical device solutions for deep brain stimulation (DBS) therapy, developing a unique, high-resolution, MRI-compatible DBS system intended to improve patient comfort and therapeutic outcomes.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Sapiens company profile →
Vapogenix Logo

Vapogenix

HQ: United States Website
  • Description: Provider of clinical-stage non-narcotic topical analgesics for localized pain, including VPX638, a Phase 2 topical for wound pain demonstrating rapid and prolonged relief without systemic side effects; a rapid-acting topical for acute procedural pain on intact skin; and a topical for localized inflammatory pain combining analgesic and anti-inflammatory effects.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Vapogenix company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Torrey Pines Therapeutics

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Torrey Pines Therapeutics

2.2 - Growth funds investing in similar companies to Torrey Pines Therapeutics

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Torrey Pines Therapeutics

4.2 - Public trading comparable groups for Torrey Pines Therapeutics

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Torrey Pines Therapeutics

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Torrey Pines Therapeutics

What does Torrey Pines Therapeutics do?

Torrey Pines Therapeutics is a provider of small molecule drug discovery and development in the United States, with a portfolio comprising candidates from proprietary drug-targeting platforms and in-licensed/acquired programs. As of August 31, 2010, the company's pipeline includes three clinical development programs.

Who are Torrey Pines Therapeutics's competitors?

Torrey Pines Therapeutics's competitors and similar companies include Eledon Pharmaceuticals, ElectroCore, Labrys Biologics, Sapiens, and Vapogenix.

Where is Torrey Pines Therapeutics headquartered?

Torrey Pines Therapeutics is headquartered in United States.

How many employees does Torrey Pines Therapeutics have?

Torrey Pines Therapeutics has 1,000 employees 🔒.

When was Torrey Pines Therapeutics founded?

Torrey Pines Therapeutics was founded in 2010 🔒.

What sector and industry vertical is Torrey Pines Therapeutics in?

Torrey Pines Therapeutics is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Torrey Pines Therapeutics

Who are the top strategic acquirers in Torrey Pines Therapeutics's sector and industry

Top strategic M&A buyers and acquirers in Torrey Pines Therapeutics's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Torrey Pines Therapeutics?

Top strategic M&A buyers groups and sectors for Torrey Pines Therapeutics include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Torrey Pines Therapeutics's sector and industry vertical

Which are the top PE firms investing in Torrey Pines Therapeutics's sector and industry vertical?

Top PE firms investing in Torrey Pines Therapeutics's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Torrey Pines Therapeutics's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Torrey Pines Therapeutics's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Torrey Pines Therapeutics's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Torrey Pines Therapeutics include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Torrey Pines Therapeutics's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Torrey Pines Therapeutics?

The key public trading comparables and valuation benchmarks for Torrey Pines Therapeutics include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Torrey Pines Therapeutics for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Torrey Pines Therapeutics with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Torrey Pines Therapeutics's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Torrey Pines Therapeutics with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Torrey Pines Therapeutics's' sector and industry vertical?

Access recent funding rounds and capital raises in Torrey Pines Therapeutics's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Torrey Pines Therapeutics